Clinical Trials Browser

Not yet recruiting × Pancreatic Neoplasms × trastuzumab deruxtecan × Clear all

NCT07619521 2026-06-02

Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a, for Advanced Pancreatic Ductal Adenocarcinoma

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms